肌肉衰竭与老年人不良结局风险:推导与多队列验证研究
本研究基于SPRINTT试验数据推导并多队列验证肌肉衰竭模型,识别出移动能力和体力活动两个主要指数。
要点
- 体力活动模型与住院和死亡关联更密切。
- 外部验证中残疾结局区分度可接受至较强。
核心结论
- 不同的移动能力测量为识别肌肉衰竭和预测老年人残疾提供了稳健框架。
- 持续活动监测可能改善对住院和死亡的预测。
- 这种结局驱动的方法支持完善肌少症评估及其在临床实践中的实施。
主要发现
- 与基于共识的肌少症定义相比,证据驱动模型对残疾的预测能力似乎更好。
临床怎么用
- 可考虑使用移动能力测量(如短距离步行速度、400米步行)识别肌肉衰竭和预测残疾风险。
- 持续活动监测可能有助于改善对住院和死亡的预测。
- 结局驱动的肌肉衰竭模型可支持肌少症评估的完善和临床实施。
局限性
- 研究无资助。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sarcopenia is inconsistently defined, and its definition might not adequately capture muscle failure, underlying disability, and other adverse outcomes in older adults. We aimed to develop and validate an evidence-based, outcome-driven model of muscle failure. METHODS: In this derivation and multicohort validation study, we analysed data from the SPRINTT randomised controlled trial (1519 participants; mean age 78·9 years [SD 5·8]; 431 [28·4%] men, 1088 (71·6%) women) and validated findings in five independent cohorts (ilSIRENTE, NHANES, HRS, ELSA, and CHARLS). Neuromuscular domains including appendicular lean mass, muscle strength and power, mobility, and physical activity were assessed. Principal component analysis identified clusters of measures, which were tested for associations with disability in mobility and disability in activities of daily living, hospitalisation, and mortality using adjusted regression models. Predictive performance was evaluated with receiver operating characteristic curves. Area under the curve (AUC) values were defined as acceptable (0·7-0·8), excellent (0·8-0·9), or outstanding (>0·9). FINDINGS: We identified two major muscle failure indexes: mobility (short-distance walking speed, 400 m walk) and physical activity (step counts, time spent standing, stepping, and sitting). In SPRINTT, the mobility model strongly predicted disability (AUC 0·721, 95% CI 0·698-0·795; p<0·0001), whereas the physical activity model was more closely associated with hospitalisation (0·646, 0·570-0·731; p=0·00040) and mortality (0·746, 0·612-0·926; p=0·0020). Combined models including mobility, handgrip strength, appendicular lean mass, and absolute muscle power improved prediction of mortality (0·746, 0·549-0·955; p=0·0076). External validation confirmed acceptable-to-strong discrimination for disability outcomes across cohorts (AUCs 0·7-0·9), while associations with hospitalisation and mortality were weaker and inconsistent (0·4-0·9). Compared with consensus-based sarcopenia definitions, the evidence-based model seemed to show better predictive ability for disability. INTERPRETATION: Distinct mobility measures provide a robust framework for identifying muscle failure and predicting disability in older adults. Continuous activity monitoring might improve prediction of hospitalisation and mortality. This outcome-driven approach supports refinement of sarcopenia assessment and its implementation in clinical practice. FUNDING: None.
引用
- Coelho-Júnior HJ, Álvarez-Bustos A, Rodríguez-Sánchez I, et al. Muscle failure and risk of adverse outcomes in older adults: a derivation and multicohort validation study. Lancet Healthy Longev. 2026. PMID: 42119578. doi:10.1016/j.lanhl.2026.100843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。